US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Ongoing

Dapsone Gel 7.5%

Reason Crystallization

Viona Pharmaceuticals INC NDC 72578-094-02 D-0011-2025
Class II · Moderate risk Ongoing

Ryaltris

Reason Defective Delivery System: The dip tube is clogged causing the spray not to work.

Glenmark Pharmaceuticals Inc., USA NDC 59467-700-27 D-0006-2025
Class II · Moderate risk Terminated

Atorvastatin Calcium Tablets

Reason Presence of Foreign Tablets/Capsules: A Carbamazepine Extended-Release 400 mg tablet was found in a 1000-count bottle of Atorvastatin Calcium Tablets, USP 40 mg.

Nivagen Pharmaceuticals Inc D-0001-2025
Class II · Moderate risk Ongoing

Pluvicto

Reason CGMP deviations

Advanced Accelerator Applications USA, Inc. NDC 69488-0010-61 D-0007-2025
Class I · High risk Terminated

Veklury

Reason Presence of Particulate Matter: Presence of glass particle.

Gilead Sciences, Inc. NDC 61958-2901-2 D-0005-2025
Class II · Moderate risk Ongoing

EnviroClean Hand Sanitizer Gel

Reason CGMP deviations

EnviroServe Chemicals Inc. NDC 76563-3010-1 D-0667-2024
Class I · High risk Ongoing

Vail-Bon Jie Yang Wan capsules

Reason Marketed without an approved NDA/ANDA: Product found to be tainted with undeclared dexamethasone and chlorpheniramine.

123Herbals D-0008-2025
Class I · High risk Terminated

Atovaquone Oral Suspension

Reason Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.

Bionpharma Inc. NDC 69452-252-87 D-0012-2025
Class II · Moderate risk Ongoing

Refresh LACRI-LUBE

Reason Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.

AbbVie Inc. D-0665-2024
Class II · Moderate risk Ongoing

Refresh P.M.

Reason Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.

AbbVie Inc. D-0664-2024
Class II · Moderate risk Terminated

Proparacaine Hydrochloride Ophthalmic Solution

Reason Temperature abuse: Products exposed to improper temperature above drug label specifications.

Mckesson Medical-Surgical Inc. Corporate Office NDC 24208-730-06 D-0661-2024
Class II · Moderate risk Terminated

Hylenex recombinant

Reason cGMP Deviations: Temperature excursion

Mckesson Medical-Surgical Inc. Corporate Office NDC 18657-117-04 D-0116-2025
Class II · Moderate risk Ongoing

First Aid Antiseptic Ointment

Reason Incorrect/Undeclared Excipients: The inactive ingredients labeled on the product boxes and tubes are listed as "mineral oil , petrolatum ". The inactive ingredients in the actual product are polyethylene glycol 400 , polyethylene glycol 4000.

Zhejiang Jingwei Pharmaceutical Co., Ltd. D-0013-2025
Class II · Moderate risk Terminated

Pyridoxine HCL

Reason Lack of Assurance of Sterility

Empower Pharmacy NDC 72627-2424-1 D-0663-2024
Class II · Moderate risk Completed

Mupirocin Ointment

Reason Subpotent Drug

Glenmark Pharmaceuticals Inc., USA NDC 68462-180-22 D-0660-2024
Class III · Low risk Ongoing

AcetaZOLAMIDE Tablets

Reason Discoloration

Rubicon Research Private Limited NDC 72888-047-01 D-0659-2024